The global and regional prevalence of hepatitis C and B co-infections among prisoners living with HIV: a systematic review and meta-analysis.
Hasan Ahmadi GharaeiMohammad FararoueiAli MirzazadehGolnaz SharifniaMarzieh Rohani-RasafDariush BastamJamileh RahimiMostafa KouhestaniShahab RezaianMostafa DianatinasabPublished in: Infectious diseases of poverty (2021)
Our findings suggested that the high prevalence of HBV and HCV co-infection among HIV-positive prisoners, particularly among those with a history of drug injection, varies significantly across the globe. The results of Meta-regression analysis showed a sliding increase in the prevalence of the studied co-infections among prisoners over the past decades, rising a call for better screening and treatment programs targeting this high-risk population. To prevent the above coinfections among prisoners, aimed public health services (e.g. harm reduction via access to clean needles), human rights, equity, and ethics are to be seriously delivered or practiced in prisons. Protocol registration number: CRD42018115707 (in the PROSPERO international).
Keyphrases
- hiv positive
- men who have sex with men
- risk factors
- public health
- antiretroviral therapy
- endothelial cells
- south africa
- randomized controlled trial
- hepatitis b virus
- healthcare
- hepatitis c virus
- human immunodeficiency virus
- global health
- big data
- induced pluripotent stem cells
- liver failure
- adverse drug
- drug delivery
- drug induced
- electronic health record
- data analysis